Clearmind Medicine Delivers Briefing to FDA Following Invitation to Historic Psychedelic Hearing in Washington, D.C.

Go back to Clearmind Medicine Delivers Briefing to FDA Following Invitation to Historic Psychedelic Hearing in Washington, D.C.
(NASDAQ: CMND) Delayed: 6.00 +0.06 (1.01%)
Previous Close $5.94    52 Week High $ 
Open $6.01    52 Week Low $ 
Day High $6.10    P/E N/A 
Day Low $6.00    EPS $ 
Volume 5,300